Artemisinin-Induced Dormancy in Malaria Parasites
Author Information
Author(s): Andrea Codd, Franka Teuscher, Dennis E. Kyle, Qin Cheng, Michelle L. Gatton
Primary Institution: Queensland Institute of Medical Research
Hypothesis
Could dormancy in malaria parasites explain the high rates of treatment failure following artemisinin monotherapy?
Conclusion
The study suggests that artemisinin-induced dormancy may contribute to treatment failures in malaria.
Supporting Evidence
- The model predicted clinical failure rates of up to 67% after a single treatment with artemisinin.
- Dormancy rates were found to significantly affect treatment failure rates.
- The study's findings align with reported treatment failure rates in field trials.
Takeaway
Some malaria parasites can go to sleep when treated with artemisinin, which might make them come back later and cause illness again.
Methodology
A computer simulation model was used to simulate the effects of artemisinin treatment on malaria parasites, incorporating dormancy rates.
Limitations
The study is theoretical and requires further in vivo confirmation of dormancy.
Participant Demographics
Malaria naïve hosts were used in the simulations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website